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Listeria monocytogenes is a bacterial pathogen that multiplies in the cytosol of host cells and spreads directly
from cell to cell by using an actin-based mechanism of motility. The broad-range phospholipase C (PC-PLC)
of L. monocytogenes contributes to bacterial escape from vacuoles formed upon cell-to-cell spread. PC-PLC is
made as an inactive proenzyme whose activation requires cleavage of an N-terminal propeptide. During
infection, PC-PLC is activated specifically in acidified vacuoles. To assess the importance of compartmental-
izing PC-PLC activity during infection, we created a mutant that makes constitutively active PC-PLC (the
plcBpro mutant). Results from intracellular growth and cell-to-cell spread assays showed that the plcBpro
mutant was sensitive to gentamicin, suggesting that unregulated PC-PLC activity causes damage to host cell
membranes. This was confirmed by the observation of a twofold increase in staining of live infected cells by a
non-membrane-permeant DNA fluorescent dye. However, membrane damage was not sufficient to cause cell
lysis and was dependent on bacterial cell-to-cell spread, suggesting that damage was localized to bacterium-
containing filopodia. Using an in vivo competitive infection assay, we observed that the plcBpro mutant was
outcompeted up to 200-fold by the wild-type strain in BALB/c mice. Virulence attenuation was greater when
mice were infected orally than when they were infected intravenously, presumably because the plcBpro mutant
was initially outcompeted in the intestines, reducing the number of mutant bacteria reaching the liver and
spleen. Together, these results emphasize the importance for L. monocytogenes virulence of compartmentalizing
the activity of PC-PLC during infection.
Listeria monocytogenes is an opportunistic bacterial patho-
gen that has the ability to remain sequestered within host cells
during its entire life cycle (15, 26). Upon entry into host cells,
bacteria escape from membrane-bound vacuoles and begin
multiplying in the cytosol of their host. During intracellular
growth, bacteria use an actin-based mechanism of motility to
induce the formation of membrane filopodia, which are taken
up by neighboring cells, enabling bacteria to spread directly
from cell to cell. The virulence of L. monocytogenes is directly
related to its efficacy at (i) escaping primary and secondary
vacuoles, formed upon initial entry into a host cell and upon
cell-to-cell spread, respectively, and (ii) remaining sequestered
within host cells (4, 7, 8, 11, 23, 26).
Bacterial factors implicated in vacuolar lysis include a pore-
forming hemolysin called listeriolysin O (LLO), a phosphati-
dylinositol-specific phospholipase C (PI-PLC), and a broad-
range phospholipase C (PC-PLC). LLO is essential for
bacterial escape from vacuoles of most cell lines (18), whereas
the phospholipases are dispensable but enhance the efficacy of
vacuolar escape (4, 23, 27). In the absence of PI-PLC, bacteria
have a significant decrease in escape from primary vacuoles
and a small defect in the ability to spread from cell to cell (4).
The absence of PC-PLC does not affect escape from primary
vacuoles but significantly reduces the bacterium’s ability to
escape secondary vacuoles (23, 27). The two bacterial phos-
pholipases appear to have overlapping functions, as a double
phospholipase mutant is more deficient in escape from second-
ary vacuoles than the sum of the defects observed with indi-
vidual mutants (23). Exceptionally, LLO is dispensable for
escape from vacuoles in cultured human cells, in which PC-
PLC can substitute for LLO in mediating vacuolar escape (10,
12, 16, 18). In vivo, LLO-negative bacteria completely fail to
grow in livers and spleens of infected mice (6), which is con-
sistent with their inability to escape from primary vacuoles. On
the other hand, PI-PLC and PC-PLC are not essential for
growth of L. monocytogenes in vivo, although individual PI-
PLC and PC-PLC deletion mutants are recovered in much
lower numbers from livers and spleens of infected mice, sup-
porting their role in virulence (4, 20).
Remarkably, the activities of these three membrane-target-
ing factors appear to be restricted to vacuolar membranes, as
infected host cells show few signs of toxicity and intracellular
bacteria are protected from gentamicin, an antibiotic that does
not diffuse across membranes (4, 18, 23). In fact, LLO’s pore-
forming ability is optimal at pH 5.9, a pH value that would be
reached only in vacuoles, and the protein has an intracellular
half-life of 15 min (2, 22). Accordingly, mutations that affect
compartmentalization of LLO activity are cytotoxic and com-
promise the ability of L. monocytogenes to remain sequestered
within host cells, resulting in severe virulence attenuation (7,
8). The activity of PC-PLC is also tightly regulated during
intracellular infection. PC-PLC is made as an inactive proen-
zyme whose activation requires proteolytic cleavage of a 24-
residue propeptide (17, 19, 27). PC-PLC activation is assisted
by a metalloprotease (Mpl) and is dependent on cell-to-cell
spread and vacuolar acidification, indicating that it occurs spe-
cifically in vacuoles (13, 19). Bacteria multiplying in the cytosol
of host cells secrete the inactive form of PC-PLC but also
maintain a pool of inactive PC-PLC at the membrane-cell wall
interface (14, 24). Similar to the case for LLO, PC-PLC se-
creted into the cytosol of infected cells is degraded by the
proteasome, with a half-life of 15 min (13). In vacuoles, the
pool of bacterium-associated PC-PLC is activated and trans-
located across the bacterial cell wall within minutes of a de-
crease in pH (14).
In this study, we investigated the biological relevance of
compartmentalizing PC-PLC activity during intracellular infec-
tion. A mutant of L. monocytogenes making a constitutively
active form of PC-PLC (the plcBpro mutant) was used. Pre-
viously, we showed that secretion and activation of this mutant
form of PC-PLC are no longer regulated by pH and by Mpl
(28). Here we report that the plcBpro mutant is not cytotoxic,
although it compromises host cell membrane integrity during
cell-to-cell spread. Remarkably, the plcBpro mutant shows
strong attenuation in mice, indicating that similar to the case
for LLO, correct compartmentalization of PC-PLC activity is
imperative for the virulence of L. monocytogenes.
MATERIALS AND METHODS
Bacterial strains and cell cultures. The L. monocytogenes 10403S wild-type
strain (3) and the isogenic mutant HEL-335 were used in this study. HEL-335,
which is identified as the plcBpro mutant, contains a deletion of the sequence
coding for the PC-PLC propeptide, generating a constitutively active form of
PC-PLC (28). In addition, strain DP-L3903, a fully virulent derivative of strain
10403S carrying Tn917 in its chromosome, was used for in vivo assays (1).
DP-L3903 is erythromycin resistant and is identified as the Emr wild type in this
paper. For tissue culture assays, the wild-type strain and the plcBpro mutant
were grown statically overnight at 30°C in brain heart infusion medium. For in
vivo assays, the Emr wild type and the plcBpro mutant were grown at 30°C (for
oral infections) or 37°C (for intravenous [i.v.] infections) at 250 rpm in brain
heart infusion broth supplemented with 200 g/ml streptomycin to an optical
density at 600 mm of 0.4 to 0.5. A regression formula was developed empirically
to determine the number of CFU per ml. The mouse macrophage-like J774 cell
line and mouse fibroblast L2 cell line were propagated in Dulbecco’s modified
Eagle’s medium supplemented with 7.5% fetal bovine serum and 2 mM glu-
tamine. Cell cultures were incubated at 37°C with 5% CO2.
Plaque assay. A plaque assay was used as an indication of bacterial cell-to-cell
spreading efficacy. The method described by Sun et al. (25) was adopted. L2 cells
(7  105) were seeded in each well of a six-well plate 2 days prior to infection
with 2 105 to 4 105 bacterial cells. At 60 min postinfection, cells were washed
three times with phosphate-buffered saline (PBS) and overlaid with a semisolid
medium containing defined concentrations of gentamicin. At 4 days postinfec-
tion, plaques were stained with neutral red. The mean plaque surface area
formed by the mutant was compared with that of the wild type. The relative
plaque size is reported as a percentage of the wild-type plaque size.
Membrane permeability assay. To assess host cell membrane integrity, live-
cell staining was performed on infected J774 cells with a fluorescent non-mem-
brane-permeant SYTOX orange nucleic acid stain (Invitrogen). J774 cells (6 
105) were seeded in glass-bottomed 35-mm dishes (MatTek Corporation) 1 day
prior to infection with 5  106 to 10  106 bacterial cells. Cells were infected 20
to 60 min apart with the wild-type and plcBpro mutant strains. Infected cells
were washed at 30 min postinfection, and gentamicin (50 g/ml) was added at 1 h
postinfection for a period of 2 h. At 6 h postinfection, infected cells were washed
with PBS, stained for 20 min at room temperature with SYTOX diluted in TBS
(25 mM Tris, pH 8.0, 150 mM NaCl, 1% bovine serum albumin), washed with
TBS, and replenished with 1 ml of clear Dulbecco’s modified Eagle’s medium.
Images were captured with a 40 lens, using a confocal microscope with a
krypton laser and transmitted light. For each experiment, images from 8 to 10
fields were captured, and 1  103 to 2  103 infected host cells were counted per
sample. The fields were chosen at random. The experiment was repeated five
times, and for each experiment the ratio of stained cells relative to the total
number of cells was determined for cells infected with the wild type or the
plcBpro mutant. Diff Quick staining was also performed on another set of
coverslips to verify that every host cell was infected.
Intracellular growth kinetics. To evaluate the bacterial ability to multiply
inside host cells, J774 cells were infected, followed by enumeration of intracel-
lular bacterial cells (18). J774 (1.5 106) cells were seeded in 60-mm petri dishes
containing 14 12-mm alcohol-flamed round coverslips 1 day prior to infection. L.
monocytogenes cells from overnight cultures were washed once with PBS, and
5  105 to 10  105 bacteria were used to infect host cells. At 30 min postin-
fection, cells were washed three times with PBS and replenished with fresh
medium. Gentamicin was added at 1 h postinfection at a final concentration of
50 g/ml to kill extracellular bacteria. To determine if gentamicin influences the
growth kinetics of intracellular bacteria, cells were washed once more with PBS
at 3 h postinfection and replenished with fresh medium, with or without genta-
micin, as indicated in the figure legends. At defined time points (2, 5, 8, and 11 h
postinfection), host cells on three coverslips were lysed by vortexing each cov-
erslip in sterile H2O for 20 s. Appropriate dilutions were then plated on Luria-
Bertani (LB) medium to determine the number of CFU per coverslip. To de-
termine the intracellular growth of bacteria devoid of cell-to-cell movement,
cytochalasin D, an inhibitor of actin polymerization, was added at a final con-
centration of 0.5 g/ml at 3 h postinfection. Experiments were repeated a min-
imum of three times. The doubling time between 5 h and 8 h postinfection was
calculated based on the following formula: ln 2/[ln (Nt/N0)/(tn  t0)], where Nt is
the number of bacteria present at a given time t (in min), N0 is the number of
bacteria present initially, and tn  t0 is the corresponding time interval between
Nt and N0.
In vivo proliferation. Six- to 8-week-old female BALB/c mice (Taconic, Hud-
son, NY) were infected with log-phase bacterial cells orally or i.v., using a
competitive index (CI) approach (1). For oral infection, mice were fasted for 2 h
prior to and after infection. Bacteria were washed once in PBS and suspended in
an appropriate volume of PBS. The Emr wild type and the plcBpro mutant were
mixed at equal concentrations, and each mouse received a 250-l dose contain-
ing approximately 4  109 CFU with a gavage needle. For i.v. infection, 200-l
inocula containing approximately 2 104 bacteria in an equal mixture of the Emr
wild type and the plcBpro mutant were injected into tail veins. At defined time
points, livers, spleens, and mesenteric lymph nodes (MLN) were harvested from
sacrificed mice and homogenized in 5 ml of buffer containing 0.5% NP-40 and
200 g/ml streptomycin. Intestines were cut longitudinally, rid of fecal materials,
rinsed in three changes of PBS (10 ml each), and homogenized in 5 ml of buffer
containing 0.5% NP-40, 0.2 mM EDTA, and 200 g/ml streptomycin. Suspen-
sions were plated on LB agar supplemented with streptomycin to recover L.
monocytogenes cells. Up to 200 colonies were streaked onto LB agar supple-
mented with 200 g/ml streptomycin and 1 g/ml erythromycin or onto activated
charcoal (0.2%)-treated LB supplemented with 25 mM glucose-1-phosphate and
1.25% egg yolk (LB-G1P-EY). While the Emr wild-type strain was resistant to
erythromycin, the plcBpro mutant was unable to grow in medium containing
erythromycin. The plcBpro mutant also exhibited an elevated level of PC-PLC
activity after 24 h of incubation at 37°C on LB-G1P-EY plates (28). The CI was
calculated by the formula CIout/CIin, where CIout is the ratio of the plcBpro
mutant to the Emr wild type postinfection and CIin is the ratio of the plcBpro
mutant to the Emr wild type in the inoculum (i.e., preinfection). A CI of 1
indicates that the Emr wild type and the plcBpro mutant proliferated equally in
the organ. In some events where no plcBpro mutant was recovered from 100
(but 200) colonies, we estimated the CIout by assuming that the next colony
would have been from the mutant strain.
Statistical analyses. Experimental data were analyzed statistically to evaluate
the significance of differences between the wild-type and mutant strains. For each
experiment from the plaque assay, the surface area of plaques formed by the
plcBpro mutant was normalized relative to that of plaques formed by the wild
type. A one-sample t test was conducted to test if the mutant plaque size was
significantly different from 100%, which was defined as the wild-type plaque size.
Likewise, for each experiment from the membrane permeability assay, the ratio
obtained with plcBpro mutant-infected cells was normalized to that obtained
with wild type-infected cells. The normalized value was tested, by a one-sample
t test, with the null hypothesis of the mean value equaling 1. Data obtained from
the intracellular growth kinetics assays were analyzed using a two-sample t test to
determine the effect of cytochalasin D on the doubling time. The mouse CI assay
was analyzed with a one-sample t test using log-transformed CI to determine if
the CI were significantly less than 1.
RESULTS
Unregulated secretion of active PC-PLC by L. monocytogenes
compromises host cell membrane integrity during intracellu-
lar infection. During intracellular infection, Mpl-mediated PC-
PLC activation occurs specifically in vacuoles and requires a
decrease in vacuolar pH (13). However, the plcBpro mutant
secretes active PC-PLC independently of Mpl and pH (28).
Constitutive secretion of active PC-PLC is not cytotoxic to the
producer bacteria. We hypothesized that the inability of L.
monocytogenes to compartmentalize PC-PLC activity during
intracellular infection would affect host cell membrane integ-
rity. To test this hypothesis, we analyzed bacterial sensitivity to
gentamicin during intracellular infection. Gentamicin was
added to the extracellular milieu to specifically kill extracellu-
lar bacteria, as it cannot diffuse across intact membranes. How-
ever, gentamicin may access the intracellular milieu if host
membrane integrity is compromised. Mouse fibroblast L2 cells
were infected and then overlaid with medium-containing soft
agar supplemented with three different concentrations of gen-
tamicin. Four days after infection, the plaques were visualized
by staining the monolayer with neutral red, a weak cationic dye
that diffuses across intact membranes and cumulates intracel-
lularly. Plaques are defined by the absence of staining, which is
an indication of major cell damage, presumably as a result of
overwhelming infection, and the size of plaques reflects the
ability of bacteria to spread from cell to cell. If host membrane
integrity was compromised early after infection, then bacterial
intracellular growth and cell-to-cell spread would be reduced.
Plaques formed by the plcBpro mutant were compared to
those formed by the wild-type strain for the same gentamicin
concentration. The surface areas of plaques formed by the
plcBpro mutant were 93% (P  0.05), 84% (P  0.02), and
81% (P  0.01) relative to that of wild-type plaques with 2, 5,
and 10 g/ml of gentamicin, respectively (Fig. 1). However, the
most striking difference was the appearance of the plaques.
Plaques formed by the wild-type strain were uniformly clear at
all gentamicin concentrations. Similarly, plaques formed by the
plcBpro mutant were uniformly clear at 2 g/ml of gentami-
cin. At 5 g/ml of gentamicin, plaques formed by the plcBpro
mutant had a clear center surrounded by a zone of partial
staining delimited by a thin clear zone. At 10 g/ml of genta-
micin, plaques formed by the plcBpro mutant showed a small
clear central zone surrounded by a large zone of different
staining intensity. The unusual appearance of plaques formed
by the plcBpro mutant at 5 and 10 g/ml of gentamicin
suggested that the antibiotic had a protective effect on host
cells, presumably by impairing the growth of intracellular
bacteria.
The plaque assay results indicated that unregulated secre-
tion of active PC-PLC affects host membrane integrity, as the
size and appearance of plaques formed by the plcBpro mu-
tant differed from those of wild-type plaques in a gentamicin-
dependent manner. To evaluate the extent of damage caused
by infection, we quantified the levels of lactate dehydrogenase
(LDH) released into the supernatants of infected murine mac-
rophage-like J774 cells, using the Cytotox 96 nonradioactive
cytotoxicity assay (Promega) according to the manufacturer’s
instructions. LDH is normally contained within the cytosol of
eukaryotic cells but is released into the extracellular milieu
upon cell lysis. Surprisingly, no differences were observed in
LDH release from samples infected with the wild type or the
plcBpro mutant strain, even when gentamicin was not used to
allow intracellular bacterial growth in permeabilized host cells
(data not shown). In agreement with this result, the appear-
ances of J774 cells infected with either bacterial strain were
indistinguishable, as determined by microscopic examination
of fixed and stained cells (Fig. 2). The nuclei and cytosol of
infected cells appeared to be normal, and bacterium-contain-
ing filopodia were observed whether or not gentamicin was
FIG. 2. Micrographs of J774 cells infected with the wild-type strain
or the plcBpro mutant. Infected host cells were washed at 30 min
postinfection. Gentamicin (50 g/ml) was added to the medium at 1 h
postinfection and maintained until the end of the experiment (top row)
or removed at 3 h postinfection (bottom row). Cells on coverslips were
stained with Diff Quick at 8 h postinfection. Images were taken with
a 60 lens.
FIG. 1. Cell-to-cell spreading efficacy of L. monocytogenes wild-
type strain (top row) and plcBpro mutant (bottom row) in infected
mouse fibroblast L2 cells in the presence of gentamicin. Infected cells
were washed at 60 min postinfection and overlaid with a semisolid
medium containing 2, 5, or 10 g/ml gentamicin. At 4 days postinfec-
tion, the monolayer was stained with neutral red, a weak cationic dye
that diffuses across intact membranes and cumulates intracellularly.
Plaques are defined by the absence of staining, which is indicative of
major cell damage or cell lysis.
present. These observations indicated that unregulated secre-
tion of active PC-PLC during intracellular infection did not
cause host cell lysis.
To evaluate host membrane integrity in a more sensitive
manner, we stained live infected cells with a fluorescent, non-
membrane-permeant nucleic acid stain. In this assay, infected
J774 cells were maintained in a gentamicin-free medium from
3 h to 6 h postinfection to prevent inhibition of intracellular
bacterial growth in damaged cells. The nucleic acid dye was
added to live cells, and the ratio of stained to unstained cells
was determined by microscopy. In this assay, twofold more
stained cells were observed in samples infected with the
plcBpro mutant than in samples infected with the wild-type
strain (P  0.018) (Fig. 3). Taken together, the results indicate
that unregulated secretion of active PC-PLC by L. monocyto-
genes during intracellular infection compromises host cell
membrane integrity without causing host cell lysis.
Host cell membrane damage occurs during cell-to-cell
spread. During intracellular infection, L. monocytogenes moves
randomly in the host cytosol, bouncing on membranes and
organelles (21). Sporadically, moving bacteria induce the for-
mation of membrane filopodia, at which point bacteria become
closely surrounded by host cell membranes. Based on the
premise that constitutive secretion of active PC-PLC compro-
mises host membrane integrity in the absence of major cell
damage or cell lysis, we hypothesized that it acts specifically on
filopodial membranes. To this end, we first determined the
intracellular growth kinetics of bacteria. In the absence of
gentamicin, the growth rate of the plcBpro mutant was the
same as that of the wild-type strain at all time points (Fig. 4).
However, the intracellular growth kinetics was influenced by
the presence of extracellular gentamicin. While the growth rate
of the plcBpro mutant was initially the same as that of the
wild-type strain (between 2 and 5 h postinfection), it was lower
than that of the wild-type strain after 5 h (Fig. 4 and Table 1).
This change in kinetics is supported by our hypothesis that
gentamicin acts on intracellular bacteria as they begin to
spread from cell to cell. To test whether or not the damage was
restricted to filopodial membranes, actin-based motility was
restricted with cytochalasin D, and thus cell-to-cell movement
was prohibited. Inhibition of cell-to-cell spread did not affect
the intracellular kinetics of the wild-type strain or the plcBpro
mutant between 2 and 5 h postinfection (data not shown). It
also did not affect the intracellular kinetics of the wild-type
FIG. 3. Staining of live infected J774 cells with a fluorescent, non-
membrane-permeant nucleic acid dye. Host cells were infected with
the wild type or the plcBpro mutant for 6 h, with the addition of 50
g/ml gentamicin between 1 h and 3 h postinfection. Live infected cells
were stained at 6 h postinfection. Images were captured with a 40
lens, using a confocal microscope with a krypton laser and transmitted
light. Host cells with compromised membranes are stained red. The
images show overlays of phase-contrast and fluorescence images of
host cells infected with the wild-type strain (A) or the plcBpro mutant
(B). (C) Ratios of stained cells to the total number of infected host
cells (1  103 to 2  103 per sample; n  5 per sample). The wild type
was set to have a ratio of 1. Statistical analysis of the data indicated that
the P value was 0.018.
FIG. 4. Growth kinetics of wild-type (squares) and plcBpro mu-
tant (inverted triangles) strains in J774 cells. Infected host cells were
washed at 30 min postinfection, and gentamicin (50 g/ml) was added
at 1 h postinfection. At 3 h postinfection, the samples were washed,
and cells were replenished with fresh medium alone (open symbols,
dotted lines) or fresh medium containing gentamicin (closed symbols,
solid lines). At 2, 5, 8, and 11 h postinfection, host cells on coverslips
were lysed to release bacteria, which were subsequently enumerated by
standard plate counts. Means 	 standard deviations for one represen-
tative experiment are shown. The experiment was repeated at least
three times.
TABLE 1. Intracellular growth rates of L. monocytogenes in J774
cells between 5 and 8 h postinfectiona
Strain Presence ofcytochalasin Db
Mean doubling time
(min)c 	 SD n P
d
Wild type  81.3 	 17.8 8 0.538
 90.3 	 34.1 5
plcBpro mutant  118.4 	 33.7 7 0.032
 74.3 	 5.6 4
a Gentamicin (50 g/ml) was present in the extracellular medium from 1 h
postinfection until the end of the experiment.
b Cytochalasin D (0.5 g/ml) was added to infected cells at 3 h postinfection.
c Doubling times were calculated as indicated in Materials and Methods.
d A two-sample t test was conducted to compare the intracellular growth rates
with and without cytochalasin D for the wild-type strain (top value). The same
test was conducted for the plcBpro mutant strain (bottom value).
strain between 5 and 8 h postinfection (Table 1). However, the
growth rate of the mutant was nearly twofold higher between
5 and 8 h postinfection in the presence of cytochalasin D. The
difference in growth rates between wild type- and plcBpro
mutant-infected cells treated with cytochalasin D was not sta-
tistically significant (P  0.36). These results indicate that the
ability of the plcBpro mutant to damage host cell membranes
is dependent on cell-to-cell spread.
Unregulated secretion of active PC-PLC compromises the
virulence of L. monocytogenes. Given that constitutive secretion
of active PC-PLC induces host cell damage in tissue culture
models, our next step was to evaluate the importance of com-
partmentalizing PC-PLC activity for the virulence of L. mono-
cytogenes in an animal model. BALB/c mice were infected
orally or intravenously with an equal mixture of two strains,
i.e., a fully virulent erythromycin-resistant derivative of the
wild-type strain (the Emr wild type) and the plcBpro mutant.
The virulence of the plcBpro mutant was evaluated by calcu-
lating the ratio of the two strains recovered from various or-
gans at specific times after infection. The results are reported
as CI, which were calculated as described in Materials and
Methods. A fully virulent strain would be expected to have a CI
of 1, whereas an attenuated strain would have a CI below 1.
For mice infected orally, CI were determined on days 2, 3, and
4 postinfection for intestines, MLN, livers, and spleens. CI
were not evaluated on day 1 for orally infected mice because
the numbers of bacteria per organ were often below detectable
levels or too low. For mice infected intravenously, bacteria
were recovered from livers and spleens as early as 7 h postin-
fection, and CI were calculated at 7 h and on days 1, 2, and 3.
In the intestines of orally infected mice, the plcBpro mu-
tant was outcompeted 
15- to 25-fold by the Emr wild type on
days 2 and 3 postinfection and 
100-fold by day 4 postinfec-
tion (Fig. 5). In livers of orally infected mice, the plcBpro
mutant was outcompeted
50-fold by the Emr wild type on day
2 postinfection and
100-fold on days 3 and 4 postinfection. In
spleens of orally infected mice, the plcBpro mutant was out-
competed
20-fold by the Emr wild type on day 2 postinfection
and 
200-fold on days 3 and 4 postinfection. In MLN, the
plcBpro mutant was outcompeted by the Emr wild type to a
lesser degree, and CI showed a large degree of variability
between mice on days 2 and 4 postinfection. Statistical analysis
of these results indicated that the plcBpro mutant was signif-
icantly outcompeted by the Emr wild type in intestines, livers,
and spleens of infected mice at all times but not in MLN on
days 2 and 4 postinfection. It is important that in some circum-
stances the mutant was not recovered and the median CI was
calculated based on some estimated values (see Materials and
Methods). The estimated CI, which are cross-marked on the
figure, are potentially higher than the actual CI. Hence, the
mutant is potentially attenuated to a greater extent than esti-
mated.
For mice infected intravenously, CI from livers and spleens
were not significantly different from 1 at 7 h postinfection,
indicating that the mutant was not defective in the first stage of
infection. As with oral infection, CI dropped below 1 in the
subsequent stages of infection, but to a lesser extent. In livers
of mice infected intravenously, the plcBpro mutant was out-
competed nearly 10-fold by the Emr wild type on days 1 and
2 postinfection and 
100-fold by day 3 postinfection. In
spleens, it took 2 days for the Emr wild type to outcompete
the plcBpro mutant. The Emr wild type outcompeted the
plcBpro mutant 4- and 35-fold by days 2 and 3 postinfec-
tion, respectively.
The median of total CFU recovered from tissues was deter-
mined and compared to the median CI to evaluate the corre-
lation between the two sets of data (Fig. 6). In most instances,
the median CI within a tissue decreased, while the median
CFU increased or remained constant, indicating that wild-type
bacteria were proliferating as the mutant was being eliminated.
Together, the results from in vivo infections indicate that the
plcBpro mutant is significantly attenuated in the mouse.
DISCUSSION
L. monocytogenes has the remarkable ability to regulate
the activities of two membrane-damaging virulence factors,
namely, LLO and PC-PLC. During intracellular infection, bac-
teria are temporarily located in membrane-bound vacuoles,
where LLO and PC-PLC operate (2, 13). Regulation of LLO
and PC-PLC activities is controlled in part by pH, as inhibition
of vacuolar acidification prohibits these factors from acting. L.
monocytogenes mutants that have lost the ability to compart-
mentalize LLO activity are cytotoxic and strongly attenuated
(7, 8). In this study, we show that an L. monocytogenes mutant
that constitutively secretes active PC-PLC is not cytotoxic.
However, this mutant compromises host cell membrane integ-
rity in a manner that is dependent on cell-to-cell spread, sug-
gesting that membrane damage is limited to filopodia formed
by moving bacteria. Moreover, the lack of compartmentaliza-
tion of PC-PLC activity during infection significantly decreases
the virulence of L. monocytogenes.
PC-PLC is made as a proenzyme whose activation requires a
decrease in pH (13). During intracellular infection, L. mono-
cytogenes maintains a pool of PC-PLC in its proform at the
membrane–cell-wall interface (24). Upon vacuolar acidifica-
tion, the pool of bacterium-associated PC-PLC is rapidly acti-
vated and translocated across the cell wall in an Mpl-depen-
dent manner (14, 28). To study the biological relevance of
regulating PC-PLC activity during intracellular infection, we
made a PC-PLC mutant whose activation and secretion are no
longer regulated by pH and Mpl (28). The behavior of this
mutant, the plcBpro mutant, was indistinguishable from that
of the isogenic wild-type strain with regard to growth kinetics
in broth and sensitivity to acid stress and bile salts (data not
shown). The only remarkable phenotypic difference was the
size of the zone of opacity generated on LB-G1P-EY plates,
indicating increased levels of PC-PLC activity (28). The
plcBpro mutant was used in this study to evaluate the impor-
tance of L. monocytogenes regulation of PC-PLC activity dur-
ing infection.
Cells infected with the plcBpro mutant did not show signs
of cytotoxicity. However, we have previously shown that pH-
induced release and activation of bacterium-associated PC-
PLC from intracellular bacteria are cytotoxic (14). In the pre-
vious study, the intracellular pH of infected cells was
equilibrated to the desired pH by using a potassium-based
buffer and a potassium ionophore, resulting in a synchronized
and rapid release of active PC-PLC from every intracellular
bacterium. This massive release of active PC-PLC in the cy-
tosol of infected cells is cytotoxic. In contrast to that phenom-
enon, the plcBpro mutant does not cumulate a pool of PC-
PLC, as the active form of PC-PLC appears to diffuse
unrestrictively across the bacterial cell wall (28). In addition,
the turnover rate of active PC-PLC in the cytosol of cells
infected with the plcBpro mutant could be high, preventing
accumulation of this enzyme to a concentration that is detri-
mental to host cells. Therefore, constant release and, perhaps,
FIG. 5. CI for the plcBpro mutant relative to the Emr wild type after oral or intravenous infection of BALB/c mice. Six- to 8-week-old female
BALB/c mice were initially infected with equal concentrations of the Emr wild type and the plcBpro mutant. At defined time points (2 to 4 days
for oral infection; 7 h and 1 to 3 days for i.v. infection), mice were sacrificed, and bacteria residing in various organs were enumerated. Livers and
spleens were harvested from mice infected intravenously. In addition to these two organs, whole intestines and MLN were harvested from mice
infected orally. Each dot represents the CI for an individual mouse. Crossed dots represent estimated CI when the mutant was not recovered from
the corresponding mice. The horizontal lines represent the median CI for each treatment group. A CI of 1 indicates that the plcBpro mutant’s
virulence was attenuated. Data were analyzed with a one-sample t test. , P  0.05; , P  0.001; , P  0.0001.
rapid turnover of active PC-PLC in the cytosol of infected cells
prevented the enzyme from causing irreversible membrane
damage.
The plcBpro mutant became sensitive to gentamicin during
intracellular infection. This sensitivity to gentamicin was abol-
ished by preventing bacteria from forming filopodia, indicating
that it was not due to an intrinsic increased bacterial sensitivity
to gentamicin but rather to leakage of the antibiotic within
infected cells as a result of filopodium formation. Concomi-
tantly, using a non-membrane-permeant nucleic acid stain,
cells were shown to be twice as sensitive to permeabilization
when infected with the plcBpro mutant as they were when
infected with the wild-type strain. It is conceivable that mem-
brane damage is more likely to occur during cell-to-cell spread
when bacteria are tightly apposed to host cell membranes in
filopodia. Release of active PC-PLC by plcBpro mutant bac-
teria in filopodia would result in localized and steady hydrolysis
of membrane phospholipids, compromising membrane integ-
rity and its ability to prevent diffusion of gentamicin. Conse-
quently, intracellular growth of bacteria would begin to stall
when moving bacteria initiate filopodium formation, which
may explain the plaquing phenotype. Plaques formed by the
wild-type strain in the presence of gentamicin at 10 g/ml were
relatively clear, whereas those formed by the plcBpro mutant
were darker after staining of the monolayers with neutral red.
Since neutral red diffuses across membranes and cumulates
within live cells, the plaquing phenotype indicates that cells
infected with the plcBpro mutant were not as damaged as
cells infected with the wild-type strain, presumably as a result
of a lower intracellular bacterial density.
The plcBpro mutant was outcompeted up to 200-fold by
the Emr wild type in a mouse competitive infection model. It is
not clear why the plcBpro mutant was attenuated in vivo. In
tissue culture cells, the mutant strain behaved similarly to the
wild-type strain with regard to invasion and escape from vacu-
oles (data not shown). Moreover, the plcBpro mutant did not
show an intracellular growth defect or a cell-to-cell spreading
defect in the absence of gentamicin. The only observed differ-
ence between the wild-type strain and the mutant was a two-
fold increase in host membrane permeability during intracel-
lular growth. Conceivably, this increase in host membrane
permeability carries greater consequences in vivo, as damaged
cells may hasten and amplify the inflammatory response to
infection. An amplified inflammatory response would have af-
fected the wild-type strain as well as the mutant strain in a
competitive assay. Absolute bacterial numbers recovered from
internal organs did not decrease overtime, but CI did, indicat-
ing that Emr wild-type bacteria were proliferating. However, it
remains a possibility that the rate of proliferation of the Emr
wild type would have been greater in the absence of the
plcBpro mutant.
The kinetics of L. monocytogenes in the initial phase of an
intravenous infection in mice has been established (9). Within
10 min of infection, 60% and 5% of bacteria are found in the
liver and the spleen, respectively, but 90% of the bacteria
reaching the liver are killed by neutrophils within the first 6 h
of infection (5, 9). It appears that the plcBpro mutant was not
more susceptible than the Emr wild type to killing by neutro-
phils, as indicated by the CI obtained at 7 h postinfection. In
addition, the plcBpro mutant was not more susceptible than
the wild-type strain to killing by activated mouse bone marrow-
derived macrophages (data not shown). However, these obser-
vations do not eliminate the possibility that damaged host cells
are better targets for inflammatory cells and, consequently,
that cells infected with the plcBpro mutant may be eliminated
more readily than those infected with the Emr wild type at a
time during infection when bacteria begin to spread from cell
to cell.
Mesenteric lymph nodes from infected mice did not show
the same CI pattern as that for other tissues. The data points
were much more scattered on days 2 and 4 post-oral infection,
and the day 4 median CI was 6- to 12-fold higher for MLN than
for intestines, livers, and spleens. Perhaps MLN are not the
main source of infection of the liver and spleen after oral
infection with L. monocytogenes.
The plcBpro mutant was more attenuated in mice infected
orally than in those infected intravenously. This difference is
unlikely due to a decreased ability of the plcBpro mutant to
invade cells of the intestinal tract, as it was not defective in
invasion of different cell lines, such as Caco-2 human intestinal
FIG. 6. Comparison of CI and total bacterial counts for tissues of infected mice. Each median CI reported in Fig. 5 is represented here in a
bar graph, in parallel with the median CFU harvested from tissues of the same group of mice. Median CI are shown with black bars and the left
y axis scale, and median CFU are shown with white bars and the right y axis scale. The left panel represents data for mice infected orally, and the
right panel represents data for mice infected i.v.
epithelial cells, L2 mouse fibroblasts, and J774 mouse macro-
phage-like cells (data not shown). In addition, the mutant was
not more sensitive than the wild-type strain to acid stress and
bile salts (data not shown). Conceivably, this difference only
reflects the inability of the mutant to perform as well as the
wild-type strain in any infected tissue. Invasion of the liver and
spleen following an oral infection takes 1 to 2 days according to
the absolute bacterial numbers obtained in the present study.
In comparison, invasion of the liver and spleen was observed at
7 h postinfection and has been reported to occur as early as 10
min postinfection following an intravenous infection (9). The
difference in attenuation between orally and intravenously in-
fected mice may simply reflect a cumulative effect of the
plcBpro mutant being outcompeted by the Emr wild type in
the intestines before translocation to the liver and spleen.
In summary, this study emphasizes the importance for L.
monocytogenes virulence of compartmentalizing the activity of
PC-PLC, a membrane-acting factor that contributes to lysis of
double-membrane vacuoles formed upon bacterial cell-to-cell
spread. Constitutive secretion of active PC-PLC during intra-
cellular infection causes host membrane damage in a cell-to-
cell spread-dependent manner and results in virulence atten-
uation in the mouse. Future studies will aim at elucidating the
mechanism contributing to plcBpro mutant attenuation in vivo.
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